Atenolol News and Research

RSS
Atenolol is a ß1 receptor specific antagonist, a drug belonging to the group of ß-blockers, a class of drugs used primarily in cardiovascular diseases. Introduced in 1976, atenolol was developed as a replacement for propranolol in the treatment of hypertension. Atenolol (trade name Tenormin) can be used to treat cardiovascular diseases and conditions such as hypertension, coronary heart disease, arrhythmias, angina (chest pain) and to treat and reduce the risk of heart complications following myocardial infarction (heart attack)
Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

Polypill plus aspirin and polypill alone reduced cardiovascular disease risk

Study shows unique cardioprotective properties of an old drug

Study shows unique cardioprotective properties of an old drug

Common high blood pressure medications do not increase risk of depression

Common high blood pressure medications do not increase risk of depression

Blood pressure lowering therapy and statins continue to improve survival in patients with hypertension

Blood pressure lowering therapy and statins continue to improve survival in patients with hypertension

New treatment for Marfan syndrome works as well as beta blockers

New treatment for Marfan syndrome works as well as beta blockers

Investigational treatment shows promise against Marfan syndrome

Investigational treatment shows promise against Marfan syndrome

New joint ESC/ESA Guidelines on non-cardiac surgery

New joint ESC/ESA Guidelines on non-cardiac surgery

Beta blocker use linked to NSCLC patient survival

Beta blocker use linked to NSCLC patient survival

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Pay more than lip service to sun-screen advice for antihypertensive users

Pay more than lip service to sun-screen advice for antihypertensive users

Beta blockers do not reduce risk of colorectal cancer

Beta blockers do not reduce risk of colorectal cancer

Weight gain or loss may also depend on medicines taken

Weight gain or loss may also depend on medicines taken

AAN updated guideline on how to best treat essential tremor

AAN updated guideline on how to best treat essential tremor

AF AWARE campaign launches Atrial Fibrillation in Primary Care tool

AF AWARE campaign launches Atrial Fibrillation in Primary Care tool

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

Chronic self-reported NSAID use associated with increased risk of adverse events in hypertensive patients with CAD

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

Anticholinergic drugs might increase risk of cognitive impairment, death in older people

Some drug mixtures may be fatal for elderly: study

Some drug mixtures may be fatal for elderly: study

Shionogi launches CUVPOSA for pediatric chronic severe drooling

Shionogi launches CUVPOSA for pediatric chronic severe drooling

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF

Sanofi-Aventis, Boehringer, World Heart Federation collaborate to raise awareness about AF